119-hr693

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 693 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 693

To amend the Office of National Drug Control Policy Reauthorization Act 
of 2006 to modify the authority of the Office of National Drug Control 
 Policy with respect to the World Anti-Doping Agency, and for other 
 purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 January 23, 2025

 Mr. Moolenaar (for himself and Mr. Krishnamoorthi) introduced the 
 following bill; which was referred to the Committee on Energy and 
 Commerce

_______________________________________________________________________

 A BILL

To amend the Office of National Drug Control Policy Reauthorization Act 
of 2006 to modify the authority of the Office of National Drug Control 
 Policy with respect to the World Anti-Doping Agency, and for other 
 purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Restoring Confidence in the World 
Anti-Doping Agency Act of 2025''.

SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH RESPECT TO THE 
 WORLD ANTI-DOPING AGENCY.

 

Section 701 of the Office of National Drug Control Policy 
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--

    (1) in subsection

    (a) --
        (A) by amending paragraph

    (1) to read as follows:
 ``

    (1) United states olympic and paralympic committee.--The 
 term `United States Olympic and Paralympic Committee' means the 
 organization established by chapter 2205 of title 36, United 
 States Code.'';
        (B) in paragraph

    (3) , by striking ``(36 U.S.C. 
 22501

    (b)

    (1) )'' and inserting ``(36 U.S.C. 
 220501

    (b)

    (1) )'';
            (C) by redesignating paragraphs

    (1) and

    (3) as 
 paragraphs

    (4) and

    (1) , respectively, and moving the 
 paragraphs so as to appear in numeric order; and
            (D) by inserting after paragraph

    (2) the following:
 ``

    (3) Independent athlete.--The term `independent athlete' 
 means an Olympic or Paralympic athlete who does not serve, in 
 any capacity--
 ``
        (A) on the International Olympic Committee;
 ``
        (B) on the International Paralympic Committee;
 ``
            (C) at an international sports federation 
 recognized by the International Olympic Committee or 
 the International Paralympic Committee;
 ``
            (D) on the United States Olympic and Paralympic 
 Committee; or
 ``
        (E) at the World Anti-Doping Agency.'';

    (2) in subsection

    (b) --
        (A) by striking ``United States Olympic Committee'' 
 each place it appears and inserting ``United States 
 Olympic and Paralympic Committee'';
        (B) in paragraph

    (5) , by striking the period at the 
 end and inserting ``; and''; and
            (C) by adding at the end the following:
 ``

    (6) carry out responsibilities with respect to the World 
 Anti-Doping Agency, as described in subsection
            (d) .''; and

    (3) by adding at the end the following:
 ``
            (d) Authority With Respect to the World Anti-Doping Agency.--
 ``

    (1) In general.--The Office of National Drug Control 
 Policy, in consultation with the United States Anti-Doping 
 Agency, the United States Olympic and Paralympic Committee, and 
 the Team USA Athletes' Commission, shall--
 ``
        (A) use all available tools to ensure that--
 ``
            (i) the World Anti-Doping Agency has a 
 credible and independent governance model that 
 provides for fair representation of the United 
 States;
 ``
            (ii) the World Anti-Doping Agency fully 
 implements all governance reforms, including a 
 proper conflict-of-interest policy for all 
 members of the Executive Committee, the 
 Foundation Board, and all relevant expert 
 advisory groups, standing committees, permanent 
 special committees, and working groups of the 
 World Anti-Doping Agency; and
 ``
            (iii) independent athletes from the 
 United States and other democratic countries, 
 or representatives of such athletes, have 
 decision-making roles on the Executive 
 Committee and the Foundation Board, and in all 
 relevant expert advisory groups, standing 
 committees, permanent special committees, and 
 working groups, of the World Anti-Doping 
 Agency;
 ``
        (B) demonstrate leadership within the global 
 community;
 ``
            (C) have strict standards that work toward 
 countering doping in every form, including by 
 countering systemic fraud through doping involving--
 ``
            (i) governmental law enforcement, 
 intelligence, or anti-doping institutions;
 ``
            (ii) sporting organizations; or
 ``
            (iii) athlete support personnel; and
 ``
            (D) work collaboratively with democratic 
 countries.
 ``

    (2) Determination.--
 ``
        (A) In general.--Not later than 90 days after the 
 date of the enactment of this subsection, the Office of 
 National Drug Control Policy, in consultation with the 
 United States Anti-Doping Agency, the United States 
 Olympic and Paralympic Committee, and the Team USA 
 Athletes' Commission, shall make a determination as to 
 whether the World Anti-Doping Agency--
 ``
            (i) has a credible and independent 
 governance model that provides for fair 
 representation of the United States;
 ``
            (ii) fully implements all governance 
 reforms, including a proper conflict-of-
 interest policy described in paragraph

    (1)
        (A)
            (ii) ; and
 ``
            (iii) allows independent athletes from 
 the United States and other democratic 
 countries, or representatives of such athletes, 
 to have decision-making roles on the Executive 
 Committee and the Foundation Board, and in all 
 relevant expert advisory groups, standing 
 committees, permanent special committees, and 
 working groups, of the World Anti-Doping 
 Agency.
 ``
        (B) Accountability.--In the case of a 
 determination under subparagraph
        (A) that the World 
 Anti-Doping Agency does not have such a governance 
 model, has not fully implemented such governance 
 reforms, or has not allowed decision-making roles 
 described in clause
            (iii) of that subparagraph, the 
 Office of National Drug Control Policy, in consultation 
 with the United States Anti-Doping Agency, the United 
 States Olympic and Paralympic Committee, and the Team 
 USA Athletes' Commission, shall--
 ``
            (i) use all available tools to ensure 
 that the United States has fair representation 
 in the World Anti-Doping Agency, including--
 ``
            (I) on the Executive Committee;
 ``
            (II) on the Foundation Board; and
 ``
            (III) in all relevant expert 
 advisory groups, standing committees, 
 permanent special committees, and 
 working groups of the World Anti-Doping 
 Agency; and
 ``
            (ii) not later than 180 days after the 
 date on which the determination under 
 subparagraph
        (A) is made, issue a report that 
 describes the barriers to participation and 
 fair representation of the United States on the 
 Executive Committee, the Foundation Board, and 
 all relevant expert advisory groups, standing 
 committees, permanent special committees, and 
 working groups of the World Anti-Doping Agency.
 ``

    (3) Voluntary nonpayment of dues.--
 ``
        (A) In general.--In the case of a determination 
 under paragraph

    (2)
        (A) that the World Anti-Doping 
 Agency does not have a governance model that provides 
 for fair representation of the United States, has not 
 fully implemented governance reforms, or has not 
 allowed decision-making roles described in clause
            (iii) of that subparagraph, the Office of National Drug 
 Control Policy, in consultation with the appropriate 
 committees of Congress, may voluntarily withhold up to 
 the full amount of membership dues to the World Anti-
 Doping Agency.
 ``
        (B) Appropriate committees of congress defined.--
 In this paragraph, the term `appropriate committees of 
 Congress' means--
 ``
            (i) the Subcommittee on Consumer 
 Protection, Product Safety, and Data Security 
 of the Committee on Commerce, Science, and 
 Transportation of the Senate (or a successor 
 subcommittee);
 ``
            (ii) the Subcommittee on Financial 
 Services and General Government of the 
 Committee on Appropriations of the Senate (or a 
 successor subcommittee);
 ``
            (iii) the Subcommittee on Oversight and 
 Investigations of the Committee on Energy and 
 Commerce of the House of Representatives (or a 
 successor subcommittee); and
 ``
            (iv) the Subcommittee on Financial 
 Services and General Government of the 
 Committee on Appropriations of the House of 
 Representatives (or a successor subcommittee).
 ``

    (4) Spending plan.--Not later than 30 days before the 
 Office of National Drug Control Policy obligates funds to the 
 World Anti-Doping Agency, the Office of National Drug Control 
 Policy shall submit to the Committee on Appropriations of the 
 Senate and the Committee on Appropriations of the House of 
 Representatives a spending plan and explanation of proposed 
 uses of such funds.''.
 <all>